The Scientific Advisory Board of GBP Captial has over 80 years of collective experience at the deepest levels of biotech research and development on leading edge therapeutics. Each of the members of the SAB are intimately familiar with the benefits and potential of lentiviral vectors and have used them extensively in their own research. In addition, the network of these individuals extends to many of the greatest minds in each of the major areas on the forefront of life-science innovation today.
Scientific Advisory Board
Scientific Advisory Board
Scientific Advisory Board |
